Literature DB >> 12037153

Cryptosporidiosis.

Xian-Ming Chen1, Janet S Keithly, Carlos V Paya, Nicholas F LaRusso.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12037153     DOI： 10.1056/NEJMra013170

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  138 in total

1.  Cholangiocyte myosin IIB is required for localized aggregation of sodium glucose cotransporter 1 to sites of Cryptosporidium parvum cellular invasion and facilitates parasite internalization.

Authors:  Steven P O'Hara; Gabriella B Gajdos; Christy E Trussoni; Patrick L Splinter; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

Review 2.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

Review 3.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

4.  The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.

Authors:  Steven P O'Hara; Aaron J Small; Jeremy B Nelson; Andrew D Badley; Xian-Ming Chen; Gregory J Gores; Nicholas F Larusso
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Cryptosporidium infection: diagnostic techniques.

Authors:  Barbara Magi; Valentina Canocchi; Giacinta Tordini; Carla Cellesi; Angela Barberi
Journal:  Parasitol Res       Date:  2005-11-18       Impact factor: 2.289

Review 6.  A review of outbreaks of cryptosporidiosis due to unpasteurized milk.

Authors:  Tamara Ursini; Lucia Moro; Ana Requena-Méndez; Giulia Bertoli; Dora Buonfrate
Journal:  Infection       Date:  2020-04-15       Impact factor: 3.553

7.  Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.

Authors:  Kovi Bessoff; Adam Sateriale; K Kyungae Lee; Christopher D Huston
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

8.  Induction of Inflammatory Responses in Splenocytes by Exosomes Released from Intestinal Epithelial Cells following Cryptosporidium parvum Infection.

Authors:  Yang Wang; Yujuan Shen; Hua Liu; Jianhai Yin; Xin-Tian Zhang; Ai-Yu Gong; Xiqiang Chen; Siyi Chen; Nicholas W Mathy; Jianping Cao; Xian-Ming Chen
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

9.  Epidemiology of Cyclospora cayetanensis and other intestinal parasites in a community in Haiti.

Authors:  Adriana S Lopez; Jean M Bendik; Jean Y Alliance; Jacquelin M Roberts; Alexandre J da Silva; Iaci N S Moura; Michael J Arrowood; Mark L Eberhard; Barbara L Herwaldt
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Induction of arginase II by intestinal epithelium promotes the uptake of L-arginine from the lumen of Cryptosporidium parvum-infected porcine ileum.

Authors:  Jody L Gookin; Stephen H Stauffer; Maria R Stone
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-10       Impact factor: 2.839
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.